Sage Journals: Discover world-class research

Abstract

3,4-methylenedioxy-methamphetamine is taken recreationally by thousands of people, especially the young, across the globe. It is highly associated with electronic music and its use in the UK remains high at around 4.5% of 16-24 year olds. This review discusses both the short- and long-term effects of 3,4-methylenedioxy-methamphetamine including methods by which some of these adverse effects can be prevented or even reversed to increase the safety of the commonly used drug.

Keywords

3 4-methylenedioxy-methamphetamine ecstasy recreational drug use danger harm to user prevention strategies potential reducing and/or reversing harmful effects

Get full access to this article

View all access options for this article.

References

Parrott

. Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research. Hum Psychopharmacol 2013; 28: 289–307.

Home Office. Drug misuse: findings from the 2016/17 crime survey for England and Wales, London: Crown, 2015.

Nichols

. Hallucinogens. Pharmacol Ther 2004; 101: 131–181.

Rang H and Dale M. CNS stimulants and psychotomimetic drugs. In: Rang and Dale’s pharmacology. 8th ed. Edinburgh: Elsevier/Churchill Livingstone, 2012, pp.589–597.

Green

Mechan

Elliott

et al.

The pharmacology and clinical pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pharmacol Rev 2003; 55: 463–508.

Rudnick

Wall

. The molecular mechanism of “ecstasy” [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci 1992; 89: 1817–1821.

Green

Cross

Goodwin

. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”). Psychopharmacology 1995; 119: 247–260.

Docherty

Green

. The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives. Br J Pharmacol 2010; 160: 1029–1044.

Green

O’Shea

Colado

. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 2004; 500: 3–13.

10.

Mas

et al.

Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 1999; 290: 136–145.

11.

Liechti Vollenweider. The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine (‘ecstasy’) in healthy volunteers. J Psychopharmacol 2000; 14: 269–274.

12.

Parrott

. Recreational ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav 2002; 71: 837–844.

13.

Curran

Travill

. Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week-end ‘high’ followed by mid-week low. Addiction 1997; 92: 821–831.

14.

McKenna

Peroutka

. Neurochemistry and neurotoxicity of 3,4-Methylenedioxymethamphetamine (MDMA, “ecstasy”). J Neurochem 1990; 54: 14–22.

15.

Dinis-Oliveira

Carvalho

Caldas

et al.

Bruxism after 3,4-methylenedioxymethamphetamine (ecstasy) abuse. Toxicol Lett 2012; 211: S55–S56.

16.

Arrue

Gomez

Giralt

. Effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’) on the jaw-opening reflex and on the alpha2-adrenoceptors which regulate this reflex in the anesthetized rat. Eur J Oral Sci 2004; 112: 127–133.

17.

Basić

. Bruxism: an unsolved problem in dental medicine. Acta Stomat Croat 2004; 1: 93–96.

18.

RollSafe – safety and supplements for MDMA/Ecstasy/X, http://www.rollsafe.org/ (2015, accessed 4 November 2015).

19.

Bluelight.org. Magnesium to stop gurning whilst under the influence of MDMA, www.bluelight.org/vb/threads/253742-magnesium-to-stop-gurning-whilst-under-the-influence-of-MDMA (2006, accessed 4 November 2015).

20.

Farah

. Ecstasy (3,4-Methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion. Pediatr Emerg Care 2008; 24: 615–617.

21.

Brvar

Kozelj

Osredkar

et al.

Polydipsia as another mechanism of hyponatremia after ‘ecstasy’ (3,4 methyldioxymethamphetamine) ingestion. Eur J Emerg Med 2004; 11: 302–304.

22.

News.bbc.co.uk. BBC ON THIS DAY | 13 | 1995: ecstasy pill puts party girl in coma, http://news.bbc.co.uk/onthisday/hi/dates/stories/november/13/newsid_2516000/2516593.stm (2015, accessed 4 November 2015).

23.

Coomber

. The control of drugs and drug users, Amsterdam: Harwood Academic Publishers, 1998.

24.

Green

Goodwin

. Ecstasy and neurodegeneration. BMJ 1996; 312: 1493–1494.

25.

Biezonski

Meyer

. The nature of 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonergic dysfunction: evidence for and against the neurodegeneration hypothesis. Curr Neuropharmacol 2011; 9: 84–90.

26.

Zhou

Chen

Zhou

et al.

3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative stress and potential free radical damage. Free Radic Res 2003; 37: 491–497.

27.

Huether

Zhou

Ruther

. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) and its congeners. J Neural Transm 1997; 104: 771–794.

28.

Green

King

Shortall

et al.

Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans. Br J Pharmacol 2012; 166: 1523–1536.

29.

Reay

. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. J Psychopharmacol 2005; 20: 385–388.

30.

McCann

Szabo

Vranesic

et al.

Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance. Psychopharmacology 2008; 200: 439–450.

31.

Briere

Fallu

Janosz

et al.

Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students. J Epidemiol Community Health 2012; 66: 990–994.

32.

Morgan

. Memory deficits associated with recreational use of “ecstasy” (MDMA). Psychopharmacology 1999; 141: 30–36.

33.

Reneman

Booij

de Bruin

et al.

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 2001; 358: 1864–1869.

34.

Parrott

. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy. J Psychopharmacol 2005; 19: 71–83.

35.

Wang

Baumann

Dersch

et al.

Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of l-5-hydroxytryptophan. Neuroscience 2007; 148: 212–220.

36.

Shen

Ali

Meyer

. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats. Neuropharmacology 2011; 61: 1183–1192.

37.

Parrott

Milani

Gouzoulis-Mayfrank

et al.

Cannabis and ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. J Neural Transm 2007; 114: 959–968.

38.

Liechti

Gamma

Vollenweider

. Gender differences in the subjective effects of MDMA. Psychopharmacology 2001; 154: 161–168.

39.

Gilhooly

Daly

. CYP2D6 deficiency, a factor in ecstasy related deaths. Br J Clin Pharmacol 2002; 54: 69–70.

40.

Tucker

Lennard

Ellis

et al.

The demethylenation of methylenedioxymethamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol 1994; 47: 1151–1156.

41.

Yang

Jamei

Heydari

et al.

Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA. J Psychopharmacol 2006; 20: 842–849.

42.

Office for National Statistics. Release edition reference tables – ONS, http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-406863 (2015, accessed 10 November 2015).

43.

DEA. TheDEA.org: ecstasy statistics, http://thedea.org/statistics.html#3 (2015, accessed 11 November 2015).

44.

Nutt

. Equasy – an overlooked addiction with implications for the current debate on drug harms. J Psychopharmacol 2009; 23: 3–5.

45.

Nutt

King

Saulsbury

et al.

Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007; 369: 1047–1053.

46.

Degenhardt

Bruno

Topp

. Is ecstasy a drug of dependence? Drug Alcohol Depend 2010; 107: 1–10.

47.

UK alcohol-related crime statistics – IAS, http://www.ias.org.uk/Alcohol-knowledge-centre/Crime-and-social-impacts/Factsheets/UK-alcohol-related-crime-statistics.aspx (2015, accessed 12 November 2015).

48.

Kraner

McCoy

Evans

et al.

Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA). J Anal Toxicol 2001; 25: 645–648.

49.

‘Superman’ pill deaths spark calls for dangerous-drugs alert system. The Guardian, http://www.theguardian.com/society/2015/jan/16/superman-pill-deaths-dangerous-drugs-alert-system (2015, 11 November 2015).

50.

Keate G. Student Calum Gill died after taking Ecstasy for first time. Thetimes.co.uk, https://www.thetimes.co.uk/article/student-calum-gill-died-after-taking-ecstasy-for-first-time-nm3w372rd (2017, accessed 12 December 2017).

51.

Ecstasy and MDMA related deaths from 2000 to 2017 – Office for National Statistics [Internet]. Ons.gov.uk. 2017 [cited 22 December 2017]. Available from: https://www.ons.gov.uk/aboutus/transparencyandgovernance/freedomofinformationfoi/ecstasyandmdmarelateddeathsfrom2000to2017.

52.

Seddon P and Noble K. G90(P) N2o laughing matter. Arch Dis Childhood 2015; 100: A37.

53.

Walker P. Teenager dies ‘after taking laughing gas’ at party in south-east London. The Guardian, http://www.theguardian.com/uk-news/2015/jul/26/teen-thought-tohave-inhaled-laughing-gas-at-london-party-in-criticalcondition (2015, accessed 23 October 2015).

54.

BBC News. Met apology for linking Ally Calvert's death to nitrous oxide – BBC News [Internet]. Available from: http://www.bbc.co.uk/news/uk-england-london-34341159 (2015, accessed 23 October 2015).

Is the recreational use of 3,4-methylenedioxy-methamphetamine safe?

Abstract

Keywords

Get full access to this article

References